Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys

Vaccine

Volumn 29, Issue 47, 2011, Pages 8624-8633

  Hu, Haixia ^a,b   Roth, Jason P ^a   Estevez, Carlos N ^a,c   Zsak, Laszlo ^a   Liu, Bo ^b   Yu, Qingzhong ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b JILIN UNIVERSITY   (China)

^c BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

Author keywords

AMPV C; Bivalent vaccine; Glycoprotein; NDV; Recombinant vector; Reverse genetics

Indexed keywords

VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN PNEUMOVIRUS; BIRD DISEASE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; INFECTION PREVENTION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PNEUMOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TURKEY (BIRD); VACCINATION; VIRUS RECOMBINANT; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; GLYCOPROTEINS; METAPNEUMOVIRUS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE INFECTIONS; POULTRY DISEASES; TURKEYS; VACCINATION; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 82455175644     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.007     Document Type: Article

References (49)

1. Gough R.E., Jones R.C. Avian metapneumovirus. Diseases of poultry 2008, 100-110. Blackwell Publishing, Ames, IA, USA. 12th ed. Y.M. Saif, A.M. Fadly, J.R. Glisson, L.R. McDougald, L.K. Nolan, D.E. Swayne (Eds.).
2. Cook J.K. Avian pneumovirus infections of turkeys and chickens. Vet J 2000, 160(2):118-125.
3. Cook J.K., Chesher J., Orthel F., Woods M.A., Orbell S.J., Baxendale W., et al. Avian pneumovirus infection of laying hens: experimental studies. Avian Pathol 2000, 29(6):545-556.
4. Jones R.C., Williams R.A., Baxter-Jones C., Savage C.E., Wilding G.P. Experimental infection of laying turkeys with rhinotracheitis virus: distribution of virus in the tissue and serological response. Avian Pathol 1988, 17:841-850.
5. Cook J.K., Ellis M.M., Huggins M.B. The pathogenesis of turkey rhinotracheitis virus in turkey poults inoculated with the virus alone or together with two strains of bacteria. Avian Pathol 1991, 20(1):155-166.
6. Lee E., Song M.S., Shin J.Y., Lee Y.M., Kim C.J., Lee Y.S., et al. Genetic characterization of avian metapneumovirus subtype C isolated from pheasants in a live bird market. Virus Res 2007, 128(1-2):18-25.
7. Toquin D., Guionie O., Jestin V., Zwingelstein F., Allee C., Eterradossi N. European and American subgroup C isolates of avian metapneumovirus belong to different genetic lineages. Virus Genes 2006, 32(1):97-103.
8. Bayon-Auboyer M.H., Arnauld C., Toquin D., Eterradossi N. Nucleotide sequences of the F, L and G protein genes of two non-A/non-B avian pneumoviruses (APV) reveal a novel APV subgroup. J Gen Virol 2000, 81(Pt 11):2723-2733.
9. Cook J.K., Orthel F., Orbell S., Woods M.A., Huggins M.B. An experimental turkey rhinotracheitis (TRT) infection in breeding turkeys and the prevention of its clinical effects using live-attenuated and inactivated TRT vaccines. Avian Pathol 1996, 25(2):231-243.
10. Ganapathy K., Bufton A., Pearson A., Lemiere S., Jones R.C. Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods. Vaccine 2010, 28(23):3944-3948.
11. Jones R.C. Viral respiratory diseases (ILT, aMPV infections, IB): are they ever under control?. Br Poult Sci 2010, 51(1):1-11.
12. Catelli E., Cecchinato M., Savage C.E., Jones R.C., Naylor C.J. Demonstration of loss of attenuation and extended field persistence of a live avian metapneumovirus vaccine. Vaccine 2006, 24(42-43):6476-6482.
13. Catelli E., Lupini C., Cecchinato M., Ricchizzi E., Brown P.A., Naylor C.J. Field avian metapneumovirus evolution avoiding vaccine induced immunity. Vaccine 2010, 28(4):916-921.
14. Cecchinato M., Catelli E., Lupini C., Ricchizzi E., Clubbe J., Battilani M., et al. Avian metapneumovirus (AMPV) attachment protein involvement in probable virus evolution concurrent with mass live vaccine introduction. Vet Microbiol 2010, 146(1-2):24-34.
15. Brown P.A., Lupini C., Catelli E., Clubbe J., Ricchizzi E., Naylor C.J. A single polymerase (L) mutation in avian metapneumovirus increased virulence and partially maintained virus viability at an elevated temperature. J Gen Virol 2011, 92(Pt 2):346-354.
16. Chacon J.L., Mizuma M., Vejarano M.P., Toquin D., Eterradossi N., Patnayak D.P., et al. Avian metapneumovirus subtypes circulating in Brazilian vaccinated and nonvaccinated chicken and turkey farms. Avian Dis 2011, 55(1):82-89.
17. Patnayak D.P., Sheikh A.M., Gulati B.R., Goyal S.M. Experimental and field evaluation of a live vaccine against avian pneumovirus. Avian Pathol 2002, 31(4):377-382.
18. Cha R.M., Khatri M., Sharma J.M. Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus. Vaccine 2011, 29(3):459-465.
19. Chary P., Njenga M.K., Sharma J.M. Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus. Vet Immunol Immunopathol 2005, 108(3-4):427-432.
20. Kapczynski D.R. Development of a virosome vaccine for protection in turkeys against avian metapneumovirus subtype C. Avian Dis 2004, 48(3):332-343.
21. Kapczynski D.R., Perkins L.L., Sellers H.S. Mucosal vaccination with formalin-inactivated avian metapneumovirus subtype C does not protect turkeys following intranasal challenge. Avian Dis 2008, 52(1):28-33.
22. Kapczynski D.R., Sellers H.S. Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus. Avian Dis 2003, 47(4):1376-1383.
23. Naylor C.J., Ling R., Edworthy N., Savage C.E., Easton A.J. Avian metapneumovirus SH gene end and G protein mutations influence the level of protection of live-vaccine candidates. J Gen Virol 2007, 88(Pt 6):1767-1775.
24. Naylor C.J., Lupini C., Brown P.A. Charged amino acids in the AMPV fusion protein have more influence on induced protection than deletion of the SH or G genes. Vaccine 2010, 28(41):6800-6807.
25. Qingzhong Y., Barrett T., Brown T.D., Cook J.K., Green P., Skinner M.A., et al. Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F). Vaccine 1994, 12(6):569-573.
26. Alexander D.J., Senne D.A. Newcastle disease, other avian paramyxoviruses, and pneumovirus infections. Diseases of poultry 2008, 75-100. Blackwell Publishing, Ames, IA, USA. 12th ed. Y.M. Saif, A.M. Fadly, J.R. Glisson, L.R. McDougald, L.K. Nolan, D.E. Swayne (Eds.).
27. Pedersen J.C., Senne D.A., Woolcock P.R., Kinde H., King D.J., Wise M.G., et al. Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America. J Clin Microbiol 2004, 42(5):2329-2334.
28. Hitchner S.B. History of biological control of poultry diseases in the USA. Avian Dis 2004, 48(1):1-8.
29. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81(1):150-158.
30. Huang Z., Elankumaran S., Yunus A.S., Samal S.K. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol 2004, 78(18):10054-10063.
31. Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., Ahmed L.E., et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 2009, 4(8):e6509.
32. Park M.S., Steel J., Garcia-Sastre A., Swayne D., Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 2006, 103(21):8203-8208.
33. Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., Starick E., et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 2006, 103(21):8197-8202.
34. Yu Q., Estevez C.N., Song M., Kapczynski D.R., Zsak L. Generation and biological assessment of recombinant avian metapneumovirus subgroup C (aMPV-C) viruses containing different length of the G gene. Virus Res 2010, 147(2):182-188.
35. Wyatt L.S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 1995, 210(1):202-205.
36. Estevez C.N., King D.J., Seal B., Yu Q. Evaluation of Newcastle disease virus chimeras expressing the hemagglutinin-neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backbone. Virus Res 2007, 129(2):182-190.
37. Alexander D.J. Newcastle disease virus and other avian paramyxoviruses. A laboratory manual for the isolation and identification of avian pathogens 1998, American Association of Avian Pathologists, Kennett Square, PA. 4th ed. D. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. Reed (Eds.).
38. Reed L.J., Muench H. A simple method for estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
39. Cook J.K., Ellis M.M., Dolby C.A., Holmes H.C., Finney P.M., Huggins M.B. A live attenuated turkey rhinotracheitis virus vaccine: 1. Stability of the attenuated strain. Avian Pathol 1989, 18:511-522.
40. Kapczynski D.R., King D.J. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 2005, 23(26):3424-3433.
41. Yu Q., Estevez C.N., Roth J.P., Hu H., Zsak L. Deletion of the M2-2 gene from avian metapneumovirus subgroup C impairs virus replication and immunogenicity in Turkeys. Virus Genes 2011, 42(3):339-346.
42. Kolakofsky D., Roux L., Garcin D., Ruigrok R.W. Paramyxovirus mRNA editing, the " rule of six" and error catastrophe: a hypothesis. J Gen Virol 2005, 86(Pt 7):1869-1877.
43. Jones R.C., Baxter-Jones C., Wilding G.P., Kelly D.F. Demonstration of a candidate virus for turkey rhinotracheitis in experimentally inoculated turkeys. Veter Rec 1986, 119(24):599-600.
44. Krishnamurthy S., Huang Z., Samal S.K. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 2000, 278(1):168-182.
45. Zhao H., Peeters B.P. Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol 2003, 84(Pt 4):781-788.
46. Lamb R.A., Parks G.D. Paramyxoviridae: the viruses and their replication. Fields virology 2007, 1440-1496. Lippincott Williams & Wilkins (a Wolters Kluwer Business), New York, NY. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman (Eds.).
47. Govindarajan D., Kim S.H., Samal S.K. Contribution of the attachment G glycoprotein to pathogenicity and immunogenicity of avian metapneumovirus subgroup C. Avian Dis 2010, 54(1):59-66.
48. Ling R., Sinkovic S., Toquin D., Guionie O., Eterradossi N., Easton A.J. Deletion of the SH gene from avian metapneumovirus has a greater impact on virus production and immunogenicity in turkeys than deletion of the G gene or M2-2 open reading frame. J Gen Virol 2008, 89(Pt 2):525-533.
49. Tarpey I., Huggins M.B., Davis P.J., Shilleto R., Orbell S.J., Cook J.K. Cloning, expression and immunogenicity of the avian pneumovirus (Colorado isolate) F protein. Avian Pathol 2001, 30(5):471-474.